Article
NOL12 Acts as an Oncogenic Biomarker and Predicts the Efficacy of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
2021-11-02
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Hepatocellular carcinoma (HCC) is a common malignancy with a poor prognosis worldwide. However, the pathogenesis of HCC remains poorly understood. <bold>Methods:</bold> Through data mining and analyses of The Cancer Genome Atlas (TCGA) datasets, the NOL12 expression in HCC was determined and the associations between its expression and patient survival and clinic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 07133d1b-2cba-533f-8faf-c702e589de13
- DOI
- 10.21203/rs.3.rs-1016997/v1